PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
23,396,448
Share change
-5,996,093
Total reported value
$14,037,047
Price per share
$0.60
Number of holders
42
Value change
-$8,719,537
Number of buys
16
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q2 2022

As of 30 Jun 2022, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,396,448 shares. The largest 10 holders included NEA Management Company, LLC, Avidity Partners Management LP, Rock Springs Capital Management LP, VANGUARD GROUP INC, MAI Capital Management, JOHNSON & JOHNSON, CHI Advisors LLC, BlackRock Inc., STIFEL FINANCIAL CORP, and DAFNA Capital Management LLC. This page lists 42 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.